Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3278609

Beta release

Statistics of Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity (vol 10, 1012, 2020)
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0500
2024-0600
2024-0700